Evaluation of Prevention of Mother to Child Transmission of Human Immunodeficiency Virus Program (Option B+), Kadoma City, Zimbabwe, 2016

Download Article

DOI: 10.21522/TIJPH.2013.04.03.Art003

Authors : Pamela N. Magande, Daniel Chirundu, Notion Gombe, Donewell Bangure, Mungati More, Tshimanga Mufuta


Background: In 2013, Zimbabwe adopted Option B+, lifelong anti-retroviral therapy (ART) for all pregnant and breastfeeding HIV positive women and Nevirapine prophylaxis for their infants as a PMTCT method. Kadoma city started implementing the same in 2014. An evaluation was done to assess progress and determine reasons for loss of follow-up to advice and improve the program.

Methods: A process-outcome program evaluation using a logical framework was conducted. Pretested interviewer administered questionnaires, checklists and monthly reports were used for data collection. Epi Info 7 was used to calculate means and frequencies. Microsoft-Excel 2013 was used to consolidate monthly reports.

Results: Thirty health workers and 43 Option B+ clients were recruited. Although resources were limited, all the 324 women who tested positive in 2014 and 2015 received ART. CD4+ monitoring increased from 54% in 2014 to 65% in 2015. All the 240 exposed infants identified within 72 hours received Nevirapine prophylaxis in 2014 and 2015. HIV positivity at six weeks in infants decreased from 4% in 2014 to 2% in 2015. Reasons given by health workers for loss to follow-up were: clients’ limited understanding (37%), poor tracking mechanisms (23%), mobility of clients (20%), religious beliefs (17%) and side effects (3%). Clients’ involvement in community support groups was poor (3%).

Conclusions: Despite limited resources, there was an improvement in Option B+ services. Reasons for loss to follow-up include poor tracking mechanisms, clients’ mobility, religious beliefs and side effects. Clients have been referred to community support groups and retention has improved.

Keywords: PMTCT, anti-retroviral therapy, Option B+, Kadoma, Zimbabwe


[1].   WHO, HIV and AIDS, Treatment of children living with HIV, http://www.who.int/hiv/topics/paediatric/en/ Accessed 29 September 2015

[2].   Averting HIV and AIDS, Children, HIV and AIDS, http://www.avert.org/children-and-hiv-aids.htm, Accessed 29 September 2015

[3].   Zimbabwe National Statistics Agency (ZIMSTAT) and ICF International. 2012. Zimbabwe Demographic and Health Survey 2010-11. Calverton, Maryland: ZIMSTAT and ICF International Inc.

[4].   Ministry of Health and Child Care, Report of Mid-Term Review of the National eMTCT Strategic Plan 2011 – 15, National AIDS and Tuberculosis Unit,August – September 2013

[5].   Ministry of Health and Child Care, Zimbabwe. An Operational Plan for the Nationwide Transition to Option B+ in Zimbabwe: September 2013-November 2014. Available at:

http://www.nac.org.zw/sites/default/files/MoHCC_OpPlan_081113.pdf. Accessed 29 September 2015

[6].   Joint United Nations Programme on HIV/AIDS. Global Plan towards the Elimination of New HIV Infections among Children by 2015 and Keeping Their Mothers Alive. Geneva, Switzerland: UNAIDS; 2011.

[7].   World Health Organization. Consolidated Guidelines on the Use of AntiretroviralDrugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. Geneva, Switzerland: WHO Department of HIV/AIDS; 2013.

[8].   Ministry of Health and Child Care, Guidelines for Antiretroviral Therapy for the Prevention and Treatment of HIV in Zimbabwe, 2013,

[9].   Recommendations for use of antiretroviral drugs in pregnant HIV-1 infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. Washington: US Public Health Service Task Force; 2005.https://aidsinfo.nih.gov/contentfiles/perinatalgl.pdf Accessed 29 September 2015

[10].   Tenthani L, Haas AD, Tweya H, Jahn A, van Oosterhout JJ, Chimbwandira F, et al. Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ('Option B+') in Malawi, AIDS, 2014 Feb 20;28(4):589-98.

[11].   Tweya H, (2014). Loss to follow-up among women in Option B+ PMTCT programme in Lilongwe, Malawi: Understanding outcomes and reasons, presentation at International AIDS Society.

[12].   Kalembo FW, Zgambo M, Loss to Followup: A Major Challenge to Successful Implementation of Prevention of Mother-to-Child Transmission of HIV-1 Programs in Sub-Saharan Africa, ISRN AIDS, 2012, 589817, 10

[13].   Nuwagaba-Biribonwoha H, Mayon-White RT, Okong P, Carpenter LM, Challenges faced by health workers in implementing the prevention of mother-to-child HIV transmission (PMTCT) programme in Uganda, Journal of Public Health, Vol. 29, No. 3, pp. 269–274

[14].   Gallant J, Adimora A, Carmichael J, Horberg M, Kitahata M, Quinlivan E, et.al.Essential Components of Effective HIV Care: A Policy Paper of the HIV Medicine Association of the Infectious Diseases Society of America and the Ryan White Medical Providers Coalition, 2011,Oxford University Press,

[15].   Balcha TT, Lecerof SS, Jeppsson AR, Strategic Challenges of PMTCT Program Implementation in Ethiopia, J IntAssoc Physicians AIDS Care (Chic), 2011, 10(3):187-92.